Compliance research

GUDID publication and distribution-end dates: separate device and package status

The acquired field reference distinguishes DI record publication, the device’s commercial-distribution end date and the higher package’s discontinue date. Some statuses are system populated. Prepare a dated device/package change plan instead of treating a public version update as proof that a device is currently sold or authorised.

Evidence retrieved 2026-10-06. Source versions and topic-specific limits are listed below.

Observed FDA field relationships

Which fields change this workflow?

FDA Data Elements Reference Table; acquired link labelled December 17, 2024. Entry conditions and edit rules below are transcribed from that version.

FieldRecorded entry conditionPost-grace-period edit ruleRecorded new-DI trigger
DI Record Publish Date [1]RequiredNoneNo
Commercial Distribution End Date [2]OptionalAdd Delete EditNo
Commercial Distribution Status [3]Auto PopulatedNANo
Package Discontinue Date [4]Conditionally Required* *If Package DI Number and Commercial Distribution End Date are entered, must also enter Package Discontinue DateAddNo
Package Status [5]Auto PopulatedNANo

Definitions and entry notes

DI Record Publish Date [1]

This date determines when a record would be publicly available on AccessGUDID.NLM.NIH.gov and OpenFDA.gov. The GUDID system adds the Grace Period (7 calendar days) to the DI Record Publish Date to calculate the public release date.

Recorded entry notes and format

Choose a date from calendar or manually enter date in format yyyy-mm-dd. An example for the calculation of when a record would be available publicly: if March 15, 2020, is entered for DI Record Publish Date, the record will display publicly on March 23, 2020. (Note: the public sites are updated on business days. If the calculated date falls on a weekend, data will display on the Monday after that weekend.) Some data elements are not allowed to be edited after the record is made available publicly (review Edit Rules after Grace Period column). We recommend you set this date to allow time to review and ensure accurate data entry.

Data type: Type: Date Format (yyyy-mm-dd) Length: 10

Entry values: NA

Commercial Distribution End Date [2]

Indicates the date the device is no longer offered for commercial distribution by the labeler on record. See 21 CFR 807.3(b) for exceptions. The device may or may not still be available for purchase in the marketplace.

Recorded entry notes and format

Choose date from calendar or manually enter date in format yyyy-mm-dd. Do not populate this field for deactivating/deleting records. Please contact the FDA UDI Help Desk at FDA UDI Help Desk. If you do not know an exact commercial distribution end date, please do not populate an estimated date.

Data type: Type: Date Format (yyyy-mm-dd) Length: 10

Entry values: NA

Commercial Distribution Status [3]

Indicates whether the device is in commercial distribution as defined under 21 CFR 807.3(b).

Recorded entry notes and format

Auto populated based on Commercial Distribution End Date. If no Commercial Distribution End Date is entered, the status is 'In Commercial Distribution'

Data type: NA

Entry values: In Commercial Distribution; Not in Commercial Distribution

Package Discontinue Date [4]

Indicates the date this particular package configuration is discontinued by the labeler.

Recorded entry notes and format

Choose date from calendar or manually enter in format yyyy-mm-dd. Discontinuation of a package is directly related to the discontinuation of the primary DI of the base package. However, a package can also be discontinued without the discontinuation of the base package.

Data type: Type: Num. (date format) Length: 10

Entry values: NA

Package Status [5]

Indicates whether the package is in commercial distribution as defined under 21 CFR 807.3(b).

Recorded entry notes and format

Auto populated based on Package Discontinue Date. If Package DI and related elements are entered and no Package Distribution End Date is entered, the status is 'In Commercial Distribution.'

Data type: NA

Entry values: In Commercial Distribution; Not in Commercial Distribution

Reference limits and edit-rule footnotes

Add = Addition of new data is allowed; Delete = Deletion of entered data is allowed; Edit = Editing of entered data is allowed; None = NO edit, add, or delete are allowed; NA = data element is not able to be changed directly; most are ‘auto-populated’ fields whose information depends on another data element Note: The above do not apply if the device is “unlocked” for editing. For more information on “unlocking” device records for editing, please visit www.fda.gov/udi [6]

See 21 CFR 830.310 and 830.340 for required data elements. [7]

Most of the information presented here is applicable to GUDID HL7 SPL submissions, but there are some differences pertinent to each submission option. Please refer to the HL7 SPL Implementation package of files for additional details on HL7 SPL xml file submission option. [8]

These are dated FDA reference-table fields, not an automated legal applicability assessment or validated submission. The AccessGUDID download schema is different from the FDA HL7 SPL submission implementation package. No quarantined schema is used.

A mapping worksheet for this workflow

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Assign the right date to the right event

    Separate intended public release, device distribution end and package discontinuation using the controlled operational records.

    Useful evidence: Release plan and dated distribution/package decisions.

  2. Review related records together

    Check affected package DIs when device distribution-end data changes; identify which reference fields are conditional and which are system populated.

    Useful evidence: Device-to-package inventory and change matrix.

  3. Reconcile after release

    Check the published device and supporting package records against the planned events; escalate differences without inferring sales or approval from status.

    Useful evidence: Post-release reconciliation and unresolved exceptions.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

US Food and Drug Administration — published reference ↗

Mon, 16 Dec 2024 01:15:52 GMT · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot f8318545152bce0733ec399fdae290591dc81d521958ea88d7f914e426703f57

  • [1] GUDID_Data_Elements!row 18 · record f6758abd64a14a61e7901f8ef59c17a6fec69b72eab35cc4595199455ff4293c
  • [2] GUDID_Data_Elements!row 19 · record cdfae911144763256ab309e254dd9a311d759207b20291819827b906a55f33c6
  • [3] GUDID_Data_Elements!row 20 · record 16dc1f83afad32f39f7fa7805433a40c6689d548ebe5e105980d4e3b8a0a1040
  • [4] GUDID_Data_Elements!row 39 · record a90f52969c21b2f3e1946bba7ae7f43a15b31dbc0a274012a69c92c3928b7f5c
  • [5] GUDID_Data_Elements!row 40 · record f5a651525ccd1abae546731d7bec15e4e7c42454793505564f49d1ee853119af
  • [6] GUDID_Data_Elements!row 98 · record 535001122b7936cad6d5c2e127d4f824c82da28cd52e80db25cabfe07c9de67c
  • [7] GUDID_Data_Elements!row 99 · record ffccb1b71368c7cd52da1fb372a1ca9e4329de68d369deee8f108ab2bdca3dd6
  • [8] GUDID_Data_Elements!row 101 · record 4cfaec69a71b8c793db9c3e66d357cbb4cefa43e640103366246094fb02f16a0

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA GUDID Submission Tools